In a Superior Court decision on November 4, 2019, the Honourable Justice Jacques Babin dismissed the plaintiff’s appeal for judicial review.
In this case, the applicant had applied for judicial review to order the Collège des médecins du Québec to rule on the prescription of typical and atypical neuroleptics that exceed the maximum recommended doses and the prescription of several neuroleptics at the same time for the same patient, following disciplinary disputes spanning several years. The applicant was the subject of two disciplinary complaints for having prescribed typical and atypical neuroleptics exceeding the maximum doses recommended by the manufacturers, and for concurrently prescribing several neuroleptics at a time for the same patient in the treatment of schizophrenia and he had been found guilty.
On January 9, 2020, the Court of Appeal dismissed Dr. Mailloux’s Application for Leave to Appeal.
Antoine Aylwin successfully advised the Collège des médecins du Québec in connection with its defence in this case.
In this case, the applicant had applied for judicial review to order the Collège des médecins du Québec to rule on the prescription of typical and atypical neuroleptics that exceed the maximum recommended doses and the prescription of several neuroleptics at the same time for the same patient, following disciplinary disputes spanning several years. The applicant was the subject of two disciplinary complaints for having prescribed typical and atypical neuroleptics exceeding the maximum doses recommended by the manufacturers, and for concurrently prescribing several neuroleptics at a time for the same patient in the treatment of schizophrenia and he had been found guilty.
On January 9, 2020, the Court of Appeal dismissed Dr. Mailloux’s Application for Leave to Appeal.
Antoine Aylwin successfully advised the Collège des médecins du Québec in connection with its defence in this case.
